IGFBP7/TAF Antibody

IGFBP7, AGM, FSTL2, IGFBP-7v, IGFBP-rP1, IBP-7, Angiomodulin, RAMSVPS, MAC25 protein, PSF, TAF, Tumor-derived adhesion factor, IGF-binding protein 7, IGFBP-7, IGFBPRP1, MAC25, PGI2-stimulating factor

Resuspension: Reconstitute with sterile water. Further information: This in an IHC-plus antibody, validated by our pathologists for use in IHC against formalin-fixed, paraffin-embedded human tissues (IHC validation procedure) . A concentration of 5 ug/ml is recommended. ELISA: To detect hIGF-BP7 by sandwich ELISA (using 100 ul/well antibody solution) a concentration of 0.5-2 ug/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with Biotinylated Anti-Human IGF-BP7 as a detection antibody, allows the detection of at least 0.2-0.4 ng/well of recombinant hIGF-BP7. Western Blot: To detect hIGF-BP7 by Western Blot analysis this antibody can be used at a concentration of 0.1-0.2 ug/ml. Used in conjunction with compatible secondary reagents the detection limit for recombinant hIGF-BP7 is 1.5-3 ng/lane, under either reducing or non-reducing conditions.